Published in Rev Rhum Mal Osteoartic on November 01, 1986
The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest (1993) 2.37
In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol (2000) 1.77
High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies'. Ann Rheum Dis (1989) 1.69
Characterisation of the rat oesophagus epithelium antigens defined by the so-called 'antikeratin antibodies', specific for rheumatoid arthritis. Ann Rheum Dis (1993) 1.13
Immunoblotting detection of so-called 'antikeratin antibodies': a new assay for the diagnosis of rheumatoid arthritis. Ann Rheum Dis (1994) 0.92
Subclass distribution of IgG antibodies to the rat oesophagus stratum corneum (so-called anti-keratin antibodies) in rheumatoid arthritis. Clin Exp Immunol (1990) 0.92
The rheumatoid arthritis-associated autoantibodies to filaggrin label the fibrous matrix of the cornified cells but not the profilaggrin-containing keratohyalin granules in human epidermis. Clin Exp Immunol (1995) 0.88
Normal human epidermal keratinocytes express in vitro specific molecular forms of (pro)filaggrin recognized by rheumatoid arthritis-associated antifilaggrin autoantibodies. Mol Med (1997) 0.76
Risk, safety, and the dark side of quality. BMJ (1997) 5.68
Prescribing errors in hospital inpatients: their incidence and clinical significance. Qual Saf Health Care (2002) 5.52
An epigenetic mutation responsible for natural variation in floral symmetry. Nature (1999) 5.32
The bearded airway. Anaesthesia (1998) 4.69
Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity (2000) 4.44
Inflorescence commitment and architecture in Arabidopsis. Science (1997) 4.26
The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol (2001) 3.92
Origin of floral asymmetry in Antirrhinum. Nature (1996) 3.74
Termination of pregnancy for maternal toxoplasmosis. Lancet (1994) 3.59
The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol (1999) 3.22
Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum (2001) 2.96
An evaluation of adverse incident reporting. J Eval Clin Pract (1999) 2.96
The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development (2001) 2.78
Control of organ asymmetry in flowers of Antirrhinum. Cell (1999) 2.74
A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet (1997) 2.68
Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team. N Engl J Med (1999) 2.67
Control of inflorescence architecture in Antirrhinum. Nature (1996) 2.56
The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest (1995) 2.37
The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest (1993) 2.37
Exploring the causes of adverse events in NHS hospital practice. J R Soc Med (2001) 2.36
Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol (2014) 2.28
Applying human factors methods to clinical risk management in obstetrics. Br J Obstet Gynaecol (1997) 2.24
Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis (2004) 2.15
Case record review of adverse events: a new approach. Qual Saf Health Care (2003) 2.15
The association of workflow interruptions and hospital doctors' workload: a prospective observational study. BMJ Qual Saf (2011) 2.13
Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell (1995) 1.99
The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol (1999) 1.93
Feedback from incident reporting: information and action to improve patient safety. Qual Saf Health Care (2009) 1.87
In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol (2000) 1.77
High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies'. Ann Rheum Dis (1989) 1.69
The safety of acupuncture. BMJ (2001) 1.62
Violations and migrations in health care: a framework for understanding and management. Qual Saf Health Care (2006) 1.60
Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol (1998) 1.59
Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum Mol Genet (1997) 1.59
Value of failure to rescue as a marker of the standard of care following reoperation for complications after colorectal resection. Br J Surg (2011) 1.59
Efficacy of essential oil of Ocimum basilicum L. and O. gratissimum L. applied as an insecticidal fumigant and powder to control Callosobruchus maculatus (Fab.) J Stored Prod Res (2001) 1.42
The impact of the Bosnian conflict on the health and mental health of New Zealanders. N Z Med J (1995) 1.40
Frozen shoulder: a new delayed complication of protease inhibitor therapy? . Rev Rhum Engl Ed (1998) 1.39
The role of bone morphogenetic proteins in vertebral development. Development (1996) 1.39
Posterior reversible encephalopathy syndrome in a context of isolated cervical spine fracture: CT angiogram as an early detector of blunt carotid artery trauma. Orthop Traumatol Surg Res (2011) 1.38
[Treatment of Horton disease. Value of synthetic antimalarials. Apropos of a retrospective study of 36 patients]. Rev Rhum Ed Fr (1994) 1.38
A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann Rheum Dis (2004) 1.36
A newly identified locus for Usher syndrome type I, USH1E, maps to chromosome 21q21. Hum Mol Genet (1997) 1.34
Control of flower development and phyllotaxy by meristem identity genes in antirrhinum. Plant Cell (1995) 1.34
Patient safety in developing countries: retrospective estimation of scale and nature of harm to patients in hospital. BMJ (2012) 1.33
Clinical complaints: a means of improving quality of care. Qual Health Care (1994) 1.32
Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides. Ann Rheum Dis (1999) 1.30
PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models. Br J Cancer (2011) 1.27
Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level. J Exp Med (1979) 1.27
Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J Immunol (2001) 1.24
Serum beta2-microglobulin in hemodialyzed patients. Nephron (1978) 1.23
Complexity, risk and simulation in learning procedural skills. Med Educ (2007) 1.22
Risks of elective cardiac surgery: what do patients want to know? Heart (2001) 1.22
Body size as an indicator of parasitoid quality in male and female Anagyrus kamali (Hymenoptera: Encyrtidae). Bull Entomol Res (2001) 1.21
The simulated operating theatre: comprehensive training for surgical teams. Qual Saf Health Care (2004) 1.18
The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane. Clin Exp Immunol (1986) 1.17
Anterior cephalic neural crest is required for forebrain viability. Development (1999) 1.15
Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis (2001) 1.15
Functional characterization of the low-molecular-mass phosphotyrosine-protein phosphatase of Acinetobacter johnsonii. J Mol Biol (1998) 1.14
Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis (1995) 1.14
Characterisation of the rat oesophagus epithelium antigens defined by the so-called 'antikeratin antibodies', specific for rheumatoid arthritis. Ann Rheum Dis (1993) 1.13
Children at risk for asthma: home allergen levels, lymphocyte proliferation, and wheeze. J Allergy Clin Immunol (2000) 1.13
Characterization of a bacterial gene encoding an autophosphorylating protein tyrosine kinase. Gene (1997) 1.12
Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients. Rev Rhum Engl Ed (1999) 1.11
Anti-beta2-microglobulin lymphocytotoxic autoantibodies in systemic lupus erythematosus. J Immunol (1979) 1.10
IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol (2005) 1.10
Seryl-tRNA synthetase from Escherichia coli: implication of its N-terminal domain in aminoacylation activity and specificity. Nucleic Acids Res (1994) 1.09
A gene responsible for a sensorineural nonsyndromic recessive deafness maps to chromosome 2p22-23. Hum Mol Genet (1996) 1.08
Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation. J Biol Chem (2001) 1.08
Observational Skill-based Clinical Assessment tool for Resuscitation (OSCAR): development and validation. Resuscitation (2011) 1.08
The peptidylarginine deiminases expressed in human epidermis differ in their substrate specificities and subcellular locations. Cell Mol Life Sci (2005) 1.08
Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes. Genes Immun (2012) 1.08
Endoscopic ultrasonography in chronic pancreatitis: a comparative prospective study with conventional ultrasonography, computed tomography, and ERCP. Pancreas (1995) 1.07
Quality improvement in multidisciplinary cancer teams: an investigation of teamwork and clinical decision-making and cross-validation of assessments. Ann Surg Oncol (2011) 1.07
Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation (1991) 1.07
Natural IgM and IgG autoantibodies to epidermal keratins in normal human sera. I: ELISA-titration, immunofluorescence study. J Invest Dermatol (1987) 1.07
Synthesis of 8-(2-4 dinitrophenyl 2-6 aminohexyl) amino-adenosine 5' triphosphate: biological properties and potential uses. Nucleic Acids Res (1982) 1.06
On the binding of ATP to the autophosphorylating protein, Ptk, of the bacterium Acinetobacter johnsonii. FEBS Lett (1999) 1.06
Beta 2-microglobulin restriction of antigen presentation. Nature (1990) 1.06
Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions. Br J Cancer (1999) 1.05
Antifilaggrin antibodies in early rheumatoid arthritis may predict radiological progression. Scand J Rheumatol (2001) 1.05